The market for prefilled syringes is believed to grow owing to factors such as increasing adoption of self-care devices, benefits associated with prefilled syringes, and high demand for improved safety in injectables.
The prefilled syringes make injections easy, accurate, and safe for both patients as well as doctors. Pre-filled syringes have emerged as one of the fastest-growing choices for unit dose medication, as the pharmaceutical industry seeks new and more convenient drug delivery methods.
In addition, pharmaceutical companies can get benefit by saving the cost of vials. The prefilled syringes work well with safety devices and auto-injection systems. Pharmaceutical companies are able to minimize drug waste and increase product life span, while patients are able to self-administer injectable drugs at their home instead of the hospital. Pre-filled syringes have also been utilized across a wide range of therapeutic sectors, such as vaccines, blood stimulants, and therapeutic proteins.
Eliminating dosing errors and ease of use are two of the greatest advantages of pre-filled syringes. Consequently, the differential advantages provided by prefilled syringes over traditional syringes are leading to its increased adoption and contributing to global market growth.
Key Market Trends Glass Prefilled Syringes are Believed to Experience Highest Growth Over the Forecast Period
The pharmaceutical industry uses glass syringes manufactured from Type 1 borosilicate glass, which consists primarily of silicon dioxide, along with oxides of boron, aluminum, sodium, and potassium. Metal ions, specifically sodium dioxide, are included in the mixture to alter the physical properties of the glass.
Glass syringes are manufactured from tubing glass. The glass tubing is created by heating the glass mixture to approximately 1500°C and continuously pulling the molten glass along a hollow spindle. Processing conditions, such as speed and airflow, are tightly controlled to prevent failures, such as airlines in the glass, from occurring. While glasses are generally unreactive, they are not necessarily inert. Alkali metals can leach out of glass, resulting in pH shifts in the solution. Some drug molecules are also labile for adsorption to the charged surface of the glass, resulting in decreased potency of the drug solution.
There have been reported instances when tungsten residues in the glass syringe Luer cone left behind during manufacturing have led to aggregation and particle formation in protein solutions. Apart from the above-mentioned challenges of drug interaction, glass prefilled syringes are also prone to breakage.
The market for glass prefilled syringes will grow regardless, albeit very sluggishly in the forecast period, primarily due to increased adoption of prefilled syringes in the developing regions, where glass syringes provide reusability and lower cost.
North America Dominates the Market
On January 22, 2013, the US FDA published the long-anticipated Final Rule: “Current Good Manufacturing Practice Requirements for Combination Products”, with the purpose of clarifying regulatory requirements for quality systems used to design, develop, and manufacture combination products, and to help ensure consistent and appropriate application and enforcement of these requirements.
Prefilled drug delivery systems, including prefilled syringes, are combination products subject to the Final Rule. From a manufactures perspective, the Final Rule, as provided by the US FDA, tightens the regulations for syringe manufacturers and has made the manufacturing operation more stringent than before. This has acted as a deterrent to global players based in the United States and prevents them from expanding their regional operations, in other regions.
Overall, there is a large concentration of vendors supplying both end products and original components in the prefilled syringe market. The use of prefilled syringes in the United States is consequently ensured by the presence of appropriate vendors. Lifestyle associated illnesses and growing demand for easy-to-administer injectables in patients of chronic disease are helping the US prefilled syringe market flourish.
Competitive Landscape The market for prefilled syringes is moderately competitive and there is high price competition in the market. The market is comprised of the global as well as local players. Most of the developing countries are having local players that provide prefilled syringes at a lower price. However, the market is majorly dominated by global companies. Few companies are expected to penetrate the market in the near future and they are beloved to grab a substantial share of the prefilled syringes market.
Reasons to Purchase this report: - The market estimate (ME) sheet in Excel format - 3 months of analyst support
Our reports have been used by over 10K customers, including:
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Syringe and Needle Market Report The syringe and needle market is expected to grow at a CAGR of over 10% during the period 2019–2025. The global syringe and needle market constitutes an essential segment of the global medical devices...
The North America pharmaceutical drug delivery market is anticipated to reach US$ 9,36,148.9 Mn by 2027 from US$ 5,60,491.5 Mn in 2019; the market is projected to grow at a CAGR of 6.8% from 2019 to 2027. The growth of the North America pharmaceutical drug delivery market is primarily attributed to the increasing prevalence of chronic...
Syringes Market Research Report by Type (Disposable Syringes, Prefilled Syringes, and Sterilizable/Reusable Syringes), by Application (Blood Specimen Collection, Drug Delivery, and Vaccination), by End-User - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Syringes Market is expected to grow from...
Injectable Drug Delivery Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Injectable Drug Delivery market including the COVID-19 pandemic implications...
179 pages •
By Global Industry Analysts
• Sep 2020
Global Veterinary Infusion Pumps Market to Reach $118.6 Million by 2027 Amid the COVID-19 crisis, the global market for Veterinary Infusion Pumps estimated at US$82.4 Million in the year 2020, is projected to reach a revised size of US$118.6 Million by 2027, growing at aCAGR of 5.3% over the period 2020-2027. Large Volume Infusion...
The syringe market was valued at US$ 12,649.46 million in 2019 and is projected to reach US$ 26,859.34 million by 2027; it is expected to grow at a CAGR of 9.8% from 2020 to 2027. The growth of the market is mainly attributed to factors such as growing number of chronic diseases and infectious diseases and increased adoption of injectable...
The increasing number of lyophilized drugs is projected to drive the dual chamber syringes market. The global dual chamber syringes market size is projected to grow from USD 131 million in 2020 to USD 182 million by 2025, at a compound annual growth rate (CAGR) of 6.8% between 2020 and 2025. The global dual chamber syringes industry has...
Rising prevalence for chronic diseases and growth in the biologics market are expected to drive the overall growth of the pharmaceutical drug delivery market. The global pharmaceutical drug delivery market is projected to reach USD 2,015.3 billion by 2025 from USD 1,430.5 billion in 2020, at a CAGR of 7.1% during the forecast period 2020-2025....
Syringes and Needles - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Syringes and Needles - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Syringes and Needles pipeline products with comparative analysis of the products...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.